Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · Real-Time Price · USD
15.47
+0.83 (5.67%)
At close: Dec 5, 2025, 4:00 PM EST
15.56
+0.09 (0.58%)
After-hours: Dec 5, 2025, 7:59 PM EST
Acadia Healthcare Company Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Acadia Healthcare Company stock have an average target of 24.38, with a low estimate of 13 and a high estimate of 66. The average target predicts an increase of 57.60% from the current stock price of 15.47.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Acadia Healthcare Company stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 6 | 4 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 2 | 3 | 3 | 3 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 12 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $17 → $14 | Hold | Maintains | $17 → $14 | -9.50% | Dec 4, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $22 → $19 | Buy | Maintains | $22 → $19 | +22.82% | Dec 3, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $22 → $17 | Hold | Maintains | $22 → $17 | +9.89% | Dec 3, 2025 |
| Keybanc | Keybanc | Buy Maintains $30 → $25 | Buy | Maintains | $30 → $25 | +61.60% | Dec 3, 2025 |
| UBS | UBS | Strong Buy Maintains $28 → $24 | Strong Buy | Maintains | $28 → $24 | +55.14% | Dec 3, 2025 |
Financial Forecast
Revenue This Year
3.36B
from 3.15B
Increased by 6.50%
Revenue Next Year
3.51B
from 3.36B
Increased by 4.38%
EPS This Year
2.40
from 2.78
Decreased by -13.58%
EPS Next Year
2.26
from 2.40
Decreased by -5.87%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.5B | 3.7B | |||
| Avg | 3.4B | 3.5B | |||
| Low | 3.2B | 3.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.5% | 8.9% | |||
| Avg | 6.5% | 4.4% | |||
| Low | 1.9% | -2.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.53 | 2.60 | |||
| Avg | 2.40 | 2.26 | |||
| Low | 2.21 | 1.71 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -9.0% | 8.4% | |||
| Avg | -13.6% | -5.9% | |||
| Low | -20.3% | -29.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.